Our press documents

You are a journalist and you would like to receive our press releases by e-mail? Please, ask to presse@pasteur.fr

Filter press documents

Candidat vaccin MV-SARS-CoV-2 : un nouveau partenariat entre l’Institut Pasteur, la CEPI, Thémis et MSD
Press release
26.05.2020
Institut Pasteur announces recent advances in the development of one of its candidate vaccines, MV-SARS-CoV-2, using...
VIH : une fenêtre de vulnérabilité pour le renouvellement du réservoir viral après allogreffe de cellules souches
Press release
07.05.2020
Current HIV treatments efficiently block viral multiplication but cannot cure infection as they do not target HIV...
Press release
30.04.2020
An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes...
Press Info
28.04.2020
Following the emergence of COVID-19 disease in Wuhan in December 2019, syndromic surveillance was implemented in France...
Press release
24.04.2020
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December...
Formule
Press release
21.04.2020
The SARS-CoV-2 global pandemic has resulted in extreme measures, with several countries imposing a lockdown on their...
Shigella
Press release
16.04.2020
The Bill & Melinda Gates Medical Research Institute (Gates MRI) and the Institut Pasteur have entered into an...
Science
Press Info
20.03.2020
On December 31, 2019, Chinese authorities reported a cluster of pneumonia cases in Wuhan, China, most of which included...
CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine
Press release
19.03.2020
Consortium to be led by the Institut Pasteur and will include Themis and the University of Pittsburgh. CEPI to provide...

Pages

 

Subscribe to our newsletter

Back to top